Buprenorphine/naloxone Treatment in Primary Care is Associated with Decreased HIV Risk Behaviors

Methadone treatment reduces HIV risk but the effects of primary care-based buprenorphine/naloxone on HIV risk are unknown. The purpose of the current study was to determine whether primary care-based buprenorphine/naloxone was associated with decreased HIV risk behavior. We conducted a longitudinal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sullivan, Lynn E., Moore, Brent A., Chawarski, Marek C., Pantalon, Michael V., Barry, Declan, O'Connor, Patrick G., Schottenfeld, Richard S., Fiellin, David A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2007
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2587397/
https://ncbi.nlm.nih.gov/pubmed/17933486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2007.08.004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares